Evidence map›Paper›PMID 31021207›Full record

ArticleThe CRISPR journal2018

ARRIGE Arrives: Toward the Responsible Use of Genome Editing.

Lluis Montoliu, Jennifer Merchant, François Hirsch, Marion Abecassis, Pierre Jouannet, Bernard Baertschi, Cyril Sarrauste de Menthière, Hervé Chneiweiss

Abstract read
In one paragraph

Article in The CRISPR journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lluis Montoliu1 National Centre for Biotechnology (CNB-CSIC), CSIC Ethics Committee and Biomedical Research Networking Centre Consortium on Rare Diseases (CIBERER-ISCIII) , Madrid, Spain .
Jennifer Merchant2 University Panthéon-Assas , Paris, France .
François Hirsch3 French National Institute for Health and Medical Research (INSERM) Ethics Committee , France .
Marion Abecassis3 French National Institute for Health and Medical Research (INSERM) Ethics Committee , France .
Pierre Jouannet3 French National Institute for Health and Medical Research (INSERM) Ethics Committee , France .
Bernard Baertschi3 French National Institute for Health and Medical Research (INSERM) Ethics Committee , France .
Cyril Sarrauste de Menthière6 Institute of Human Genetics (IGH), National Center for Scientific Research (CNRS), University of Montpellier , Montpellier, France .
Hervé Chneiweiss3 French National Institute for Health and Medical Research (INSERM) Ethics Committee , France .

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID31021207
PMCPMC6636865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.